Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB26FTL67
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,775
Award facts
- Contract value 100% obligated
- $17,774.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,774.53 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg in a 2-pen/mL dose configuration on November 10, 2025, with completion targeted for November 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
Cosentyx is a biologic immunosuppressant medication used to treat autoimmune conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis. As a major pharmaceutical distributor serving federal healthcare systems, AmerisourceBergen fulfills critical medical supply needs for military, veteran, and other government healthcare programs through its expansive product portfolio. This delivery order exemplifies the company's role in supporting the Defense Health Agency and other federal customers through flexible contract vehicles that enable rapid procurement of specialized pharmaceutical products across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FTL67?
SPE2DB26FTL67 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DB26FTL67 worth?
The government has obligated $17,775 on SPE2DB26FTL67.
Is contract SPE2DB26FTL67 an order under another contract?
Yes. SPE2DB26FTL67 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB26FTL67 competed?
The extent of competition for SPE2DB26FTL67 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award